For previously vaccinated Canadians, the latest national recommendation is a dose of an XBB.1.5-containing formulation of COVID-19 vaccine.
Recommended for individuals 5 and up!
COMIRNATY is recommended by the Canadian Paediatric Societyfor children aged 5 to 11 years old.
COMIRNATY is recommended by the National Advisory Committee
on Immunization (NACI) for people aged 5 to 29 years old.
Now indicated for infants 6 months to under 5 years old
The National Advisory Committee on Immunization (NACI) has recommended that for those
previously vaccinated against COVID-19, a dose of a formulation of COVID-19 vaccine containing XBB.1.5 is recommended and should be received beginning in the fall of 2023.
previously vaccinated against COVID-19, a dose of a formulation of COVID-19 vaccine containing XBB.1.5 is recommended and should be received beginning in the fall of 2023.
Get information about Canadian vaccination recommendations
Learn more
What are the National Advisory Committee on Immunization’s recommendations for COVID-19 vaccination?
Book your next vaccine appointment today!